SIRT2 may cause dopaminergic neuronal death [74]; in in vitro and in vivo models of PD, pharmacologic or genetic inhibition of SIRT2 protects against α-synuclein toxicity [36,75]. The gene discussed is SIRT2; the disease is Parkinson disease.